top of page

Pliant's CEO on targeting integrins to treat fibrotic diseases like IPF and liver disease

Bernard Coulie gives a deep dive into Pliant's IPF program, including news released this morning relating to patient PET scans.





Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page